Caso de paralisia bilateral de quarto nervo associada com síndrome do pseudotumor
            cerebral

Totuk, Özgün Melike Gedar; Aldroubı, Nesrin; Aykan, Ümit

doi:10.5935/0004-2749.20190061

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Trochlear nerve palsy has been described in case reports of mainly teenagers with IIH [10 & ]. Some of these cases have been associated with use of medications including minocycline, topical Vitamin A, and nalidixic acid [40][41][42]. This underscores the importance of taking an accurate medication history in all patients presenting with an IIH syndrome.…”

Section: Idiopathic Intracranial Hypertension With Unusual Cranial Ne...mentioning

confidence: 99%

Expanding the clinical spectrum of idiopathic intracranial hypertension

Chen

Britton

2022

Current Opinion in Neurology

View full text Add to dashboard Cite

Purpose of reviewIdiopathic intracranial hypertension (IIH) is a disorder of raised intracranial pressure (ICP). Although the majority of patients with IIH present classically with headache and papilledema, some patients may have unusual presentations or manifestations. Recent advancements in neuroimaging have facilitated the identification of other presentations associated with IIH. This review provides an overview of the expanding clinical spectrum of IIH. Recent findingsPresentations of IIH that are considered unusual include highly asymmetric or unilateral papilledema, IIH without papilledema, and IIH associated with cranial nerve involvement. These presentations likely reflect differences in the way cerebrospinal fluid (CSF) pressure is transmitted intracranially. Radiological signs of intracranial hypertension are increasingly recognized in patients with IIH and provide further insights into the effects of raised ICP on intracranial structures. Osseous changes in the skull base leading to formation of meningoceles and encephaloceles have been identified in patients with IIH, spontaneous skull base CSF leak, and drug-resistant temporal lobe epilepsy, suggesting a possible association. SummaryClinicians should be familiar with the expanding clinical spectrum of IIH and the implications for the management of these presentations. Keywords idiopathic intracranial hypertension, MRI, raised intracranial pressure, spontaneous cerebrospinal fluid leak, temporal lobe epilepsy ]. Papilledema is an 'outstanding objective finding' of IIH [2] and is the key diagnostic criterion in

show abstract

Section: Idiopathic Intracranial Hypertension With Unusual Cranial Ne...mentioning

confidence: 99%

Expanding the clinical spectrum of idiopathic intracranial hypertension

Chen

Britton

2022

Current Opinion in Neurology

View full text Add to dashboard Cite

show abstract

“…We interpreted these additional findings as a fourth cranial nerve palsy which has been shown to rarely occur in primary IH and may cause mild exotropia and/or vertical preference on primary gaze; the former of which was absent because of concomitant sixth cranial nerve palsy. 1 Visual acuity on the right eye was “no light perception,” the left was “counting fingers” intact at 1 inch. She was sent to the ER where she also endorsed worsened neck stiffness and eye pain.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Vaccination May Provoke Intracranial Hypertension

Melendez-Zaidi

Foroozan

Orman

et al. 2022

Journal of Pediatric Neurology

View full text Add to dashboard Cite

In parallel to the spread of the novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), there has been the growing recognition that active SARS-CoV-2 infection has the potential to effect both the peripheral and central nervous systems. When it comes to the SARS-CoV-2 vaccine, however, reporting has been more uncertain. As the vaccination rate has risen, we have seen a rise in rare neurological complications thought to be associated with the vaccination including acute transverse myelitis, Guillain–Barre syndrome, optic neuritis, and Tolosa–Hunt syndrome. The Centers for Disease Control and Prevention (CDC) estimates 98 confirmed cases of Guillain–Barre syndrome out of 12.6 million doses. Given the initial age limits of vaccination eligibility, most reports have been limited to the adult population. Here, we report a case of intracranial hypertension (IH), evolving to fulminant IH in a healthy female after receiving the SARS-CoV-2 vaccine. While elevated intracranial pressure has been reported in the context of active SARS-CoV-2 infections and postinfection multisystem inflammatory syndrome (MIS-C), this is the first reported case of pediatric IH after vaccination alone.

show abstract